A detailed history of Toroso Investments, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Toroso Investments, LLC holds 246,001 shares of CTMX stock, worth $268,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246,001
Holding current value
$268,141
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$1.12 - $1.51 $275,521 - $371,461
246,001 New
246,001 $290,000
Q2 2024

Aug 14, 2024

SELL
$1.21 - $5.13 $36,421 - $154,413
-30,100 Reduced 10.45%
258,001 $314,000
Q1 2024

May 15, 2024

SELL
$1.41 - $2.74 $25,388 - $49,336
-18,006 Reduced 5.88%
288,101 $628,000
Q4 2023

Feb 14, 2024

SELL
$1.07 - $1.55 $12,844 - $18,606
-12,004 Reduced 3.77%
306,107 $474,000
Q1 2023

May 15, 2023

SELL
$1.48 - $2.88 $41,135 - $80,046
-27,794 Reduced 8.04%
318,111 $480,000
Q4 2022

Feb 15, 2023

BUY
$1.19 - $1.91 $41,162 - $66,066
34,590 Added 11.11%
345,905 $553,000
Q3 2022

Nov 23, 2022

BUY
$1.23 - $1.97 $127,357 - $203,979
103,543 Added 49.83%
311,315 $451,000
Q2 2022

Aug 15, 2022

BUY
$1.53 - $2.89 $317,891 - $600,461
207,772 New
207,772 $380,000

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $71.9M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.